Ilomastat (GM6001, Galardin)
Molecular Weight(MW): 388.46
Ilomastat (GM6001, Galardin) is a broad spectrum matrix metalloprotease (MMP) inhibitor for MMP-1, MMP-2, MMP-3, MMP-7, MMP-8, MMP-9, MMP-12, MMP-14, and MMP-26 with Ki of 0.4 nM, 0.5 nM, 27 nM, 3.7 nM, 0.1 nM, 0.2 nM, 3.6 nM, 13.4 nM, 0.36 nM, respectively.
Cited by 11 Publications
5 Customer Reviews
ARPE-19 cells were seeded on Millicell inserts for growth to form the monolayer. Monolayers were treated with or without recombinant HIV-1 gp120 glycoprotein during the last 2 days of cell culture. Some samples were pretreated with anti-DC-SIGN antibodies or GM6001 before incubation with gp120. A, the TEER value was measured. B, the paracellular permeability for FITC-dextran flux was assessed. Date represent mean ± S.D. *, p < 0.05; **, p < 0.01; ***, p < 0.001. Ω, ohm.
J Biol Chem, 2016, 291(44):22977-22987. Ilomastat (GM6001, Galardin) purchased from Selleck.
GM6001 inhibits MMP-7 and −10 mRNA expressions in Aurora-A stable cells in HNC. The mRNA expression levels of MMP-7 and −10 were examined by Q-RT-PCR in FaDu/vehicle, and FaDu/Aurora-A transfectants treated with DMSO or GM6001 in a dose-dependent manner. Statistical analysis: **p < 0.01, ***p < 0.001.
Mol Cancer, 2015, 14(1):83.. Ilomastat (GM6001, Galardin) purchased from Selleck.
Immunofluorescence images of MMP-2 and MMP-9 in the ischemic brain 1 h after probe injection confirmed the sensitivity of the MMP-P12 probe in quantifying reduced MMP activity in response to MMP-specific inhibitors on day 7 post stroke (n = 5 per group).
Sci Rep, 2015, 5:16951. Ilomastat (GM6001, Galardin) purchased from Selleck.
Immunoblotting of whole cell lysates obtained from phLFs treated with 1 ng/ml TGF-1 together with specific inhibitor targeting matrix metalloproteinases (MMPs; GM6001) every 24 h for a total 48-h treatment period. Cell lysates were probed for CDCP1, α-SMA and βactin. β-actin was used as a loading control. Untreated samples are indicated by “wo.” Each blot is representative of 3 independent experiments
Am J Physiol Lung Cell Mol Physiol, 2018, 314(5):L695-L707. Ilomastat (GM6001, Galardin) purchased from Selleck.
Effect of the broad spectrum hydroxamate inhibitors batimastat and ilomastat on a disintegrin and metalloproteinase with thombospondin type 1 motifs (ADAMTS) 13 and ADAMTS15. (A) While batimastat is a good inhibitor against ADAMTS15, ilomastat has no ability to inhibit the enzyme. ADAMTS15 (20 nM) was pre-incubated with two doses (300 nM or 3 µM) of batimastat and ilomastat prior to the addition of aggrecan substrate G1-IGD-G2. The inhibitory effect of batimastat can be clearly discerned from the undigested 130 kDa G1-IGD-G2 bands.
Biomed Rep, 2016, 4(1):73-78. . Ilomastat (GM6001, Galardin) purchased from Selleck.
Purity & Quality Control
Choose Selective MMP Inhibitors
|Description||Ilomastat (GM6001, Galardin) is a broad spectrum matrix metalloprotease (MMP) inhibitor for MMP-1, MMP-2, MMP-3, MMP-7, MMP-8, MMP-9, MMP-12, MMP-14, and MMP-26 with Ki of 0.4 nM, 0.5 nM, 27 nM, 3.7 nM, 0.1 nM, 0.2 nM, 3.6 nM, 13.4 nM, 0.36 nM, respectively.|
GM6001 inhibits human skin fibroblast collagenase with Ki of 0.4 nM when assayed with a synthetic thio ester substrate at pH 6.5, with 50-fold selectivity over two bacterial enzymes, thermolysin and Pseudomonas aeruginosa elastase.  GM 6001 (0.1 nM - 10 nM) inhibits gelatinase A and gelatinase B produced by T-cells, thus inhibits T-cell homing. 
|In vivo||Topical application of GM6001 (400 μg/ml) prevents corneal ulceration after severe alkali injury.  In rabbit model after stenting, GM6001 significantly inhibits intimal hyperplasia and intimalcollagen content, and it increases lumen area in stented arteries without effects on proliferation rates. |
|In vitro||DMSO||78 mg/mL (200.79 mM)|
|Ethanol||8 mg/mL warmed (20.59 mM)|
|In vivo||Add solvents to the product individually and in order(Data is from Selleck tests instead of citations):
2% DMSO+40% PEG 300+2% Tween 80+ddH2O
For best results, use promptly after mixing.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).
Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )
* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).
Molecular Weight Calculator
Enter the chemical formula of a compound to calculate its molar mass and elemental composition:
Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2
Instructions to calculate molar mass (molecular weight) of a chemical compound:
To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.